neurodegenerative-diseases

Documents about neurodegenerative-diseases

• Ccf mtDNA as a Neurodegenerative Biomarker#969370ClinicalTrials.gov
• Randomized Control Trial of Small-Molecule Natural Flavonoids Intervention for Neurodegenerative Diseases#859094ClinicalTrials.gov
• Immunohistochemical Study of Neurodegenerative Diseases#858112ClinicalTrials.gov
• Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative Diseases#813652ClinicalTrials.gov
• Retinal Neurodegenerative Signs in Alzheimer's Diseases#893208ClinicalTrials.gov
• Blood biomarkers in neurodegenerative diseases: pre-analytical, analytical, and post-analytical challenges#254039HAL (France)
• Study of Neurodegenerative Diseases Induced Stem Cells in Patients and Healthy Family Controls.#872016ClinicalTrials.gov
• Attitudes toward cannabidiol use among Bulgarian patients with neurodegenerative diseases and chronic pain#407476ARPHA OAI-PMH Endpoint
• Phase separation and protein aggregation in neurodegenerative diseases#357342HAL (France)
• CLARA Testbed: HPCQC Infrastructure to Accelerate Research in Brain Science and Neurodegenerative Diseases#26405DataCite
• CLARA Testbed: HPCQC Infrastructure to Accelerate Research in Brain Science and Neurodegenerative Diseases#26406DataCite
• Speech and language characterization for neurodegenerative diseases detection#419380Spectrum: Concordia University Research Repository
• Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases#8060HAL (France)
• Saliva and Extracellular Vesicles for Neurodegenerative Diseases#874407ClinicalTrials.gov
• A framework of digital biomarkers for neurodegenerative diseases.#255395NCBI PubMed Central
• Citicoline Concentration in Human Vitreous#633779ClinicalTrials.gov
• Computerized Cognitive Training in Neurodegenerative Diseases (NDD2019)#845242ClinicalTrials.gov
• Dyskinesia in Parkinson's Disease (Study P04501)#825661ClinicalTrials.gov
• Normative Speech Modeling for ALS Diagnosis with Application to Other Neurodegenerative Diseases#310944bioRxiv / medRxiv
• Targeting mitochondria for the treatment of neurodegenerative diseases.#430890NCBI PubMed Central
• Dataset: network pharmacology, molecular docking and molecular dynamics analysis of pterostilbene targets in neurodegenerative diseases#206720RepOD Dataverse OAI Archive
• Neurodegenerative Diseases Progression Markers (MARKERS-NDD)#825305ClinicalTrials.gov
• Research on RARs in neurodegenerative diseases: A bibliometric analysis.#323033NCBI PubMed Central
• Characterizing the heterogeneity of neurodegenerative diseases through EEG normative modeling#377998HAL (France)
• The locus coeruleus – norepinephrine system as a regulator of social perception#637121PsyArXiv
• Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders#840159ClinicalTrials.gov
• Reversible & Microbubble Concentration-Dependent Permeabilization of an In Vitro Human Endothelial Barrier to Small Molecules Using Ultrasound: Implications for Neurodegenerative Diseases Therapy#280548HAL (France)
• Editorial: The role of the cerebellum in dementia and neurodegenerative diseases#223188Ora Oxford University Research
• Validation of the NeuroTec Loft#917391ClinicalTrials.gov
• Targeting non-apoptotic regulated cell death (RCD) to treat neurodegenerative diseases.#224841NCBI PubMed Central
• Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases#384812HAL (France)
• REDDI: A Riemannian Ensemble Learning Framework for Interpretable Differential Diagnosis of Neurodegenerative Diseases#633116bioRxiv / medRxiv
• Dementia Specific Respite Care Concept.#812063ClinicalTrials.gov
• The locus coeruleus – norepinephrine system as a regulator of social perception#637556OSF
• Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)#967786ClinicalTrials.gov
• Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease#856088ClinicalTrials.gov
• Exploring neuronal circuitry in neurodegenerative diseases: from traditional models to cutting-edge techniques#274697IRIS
• Exploratory Evaluation of [11C]MPC6827#909235ClinicalTrials.gov
• Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study#454106ClinicalTrials.gov
• Caffeine for Motor Manifestations of Parkinson's Disease#831515ClinicalTrials.gov
• Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease#844224ClinicalTrials.gov
• Oligonucleotide-Recognizing Topoisomerase Inhibitors (OTIs): precision gene editors for neurodegenerative diseases?#287221Birkbeck Institutional Research Online
• Targeting the cardio-neuro axis through nutrition: inflammatory mechanisms linking cardiovascular and neurodegenerative diseases.#378337NCBI PubMed Central
• Genetically predicted telomere length and its relationship with neurodegenerative diseases and life expectancy.#646731Repisalud
• An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196#896852ClinicalTrials.gov
• Pilot Study to Evaluate the Self-Management of Gait, Speech, and Dexterity Symptoms in Parkinson's Disease Using a Smartphone Application#876049ClinicalTrials.gov
• Effect of data leakage in brain MRI classification using 2D convolutional neural networks#250578IRIS
• The Associations Between Dietary Flavonoid Intake and Neurodegenerative Diseases Risk: A Cross-Sectional Study.#312439NCBI PubMed Central
• The Role of Humanoid Robot in Neuropsychological Assessment and Cognitive Training.#889898ClinicalTrials.gov
• Figure 2 from: Gesheva T, Boycheva N, Todorova G, Mihaylova A (2026) Attitudes toward cannabidiol use among Bulgarian patients with neurodegenerative diseases and chronic pain. Pharmacia 73: e203129. https://doi.org/10.3897/pharmacia.73.e203129#463027Zenodo (CERN)

Related topics